A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

His studies showed that a B vitamin deficiency could cause hardened arteries. It took the medical profession more than a ...

Laurie Labishak, marketing director for Trinity Health System, told the many attending the medical system’s first Crimson ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...

Women of childbearing age who had both ovaries removed in a procedure called bilateral oophorectomy were more likely to ...

(Reuters) -U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its heart disease drug, setting the stage for the 23-year-old biotech's next phase of growth.

Discover how menopause affects heart health through hormonal changes, cholesterol shifts, body fat redistribution, blood ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...